AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
AXIM Biotechnologies's price to sales ratio was 9.7× on Oct 19, 2026, against 31.7× a year earlier. Over the last 5 years it ranged from 6.0× to 498.7×, with a median of 45.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 9.7× | −24.2 |
| 2025 | Dec 31, 2025 | 33.9× | +27.9 |
| 2024 | Dec 31, 2024 | 6.0× | −125.0 |
| 2023 | Dec 29, 2023 | 131.0× | −86.9 |
| 2022 | Jul 29, 2022 | 217.9× | +152.1 |
| 2021 | Jan 29, 2021 | 65.8× | −2.0 |
| 2020 | Dec 31, 2020 | 67.8× | −56.7 |
| 2019 | Dec 31, 2019 | 124.5× | −29.9 |
| 2016 | Sep 30, 2016 | 154.4× | −195.8 |
| 2015 | Dec 31, 2015 | 350.2× | – |
See a number that looks wrong?